CAXTON CORP Diversified Active

CIK: 0001388551 · Show all filings

Period: Q3 2025 (← Previous) (Next →)

Filing Date: Nov 14, 2025

Total Value ($000): $22,859 (100.0% shares, 0.0% debt)

Holdings (12)

RZLT REZOLUTE INC 81.7%

Value ($000) $18,676 Shares 1,986,818 Est. Cost $8.14 Unrealized -18.2%

GLD SPDR GOLD TR 11.3%

Value ($000) $2,590 Shares 7,286 Est. Cost $310.70 Unrealized —

BRK/B BERKSHIRE HATHAWAY INC DEL 1.4%

Value ($000) $327 Shares 651 Est. Cost $401.81 Unrealized +20.5%

— MIND MEDICINE MINDMED INC 1.4%

Value ($000) $318 Shares 27,011 Est. Cost $8.91 Unrealized —

ELVN ENLIVEN THERAPEUTICS INC 1.2%

Value ($000) $268 Shares 13,097 Est. Cost $18.93 Unrealized +6.5%

CMPX COMPASS THERAPEUTICS INC 0.8%

Value ($000) $187 Shares 53,503 Est. Cost $3.22 Unrealized -1.9%

BCAX BICARA THERAPEUTICS INC 0.8%

Value ($000) $173 Shares 10,941 Est. Cost $25.50 Unrealized -56.1%

KYTX KYVERNA THERAPEUTICS INC 0.6%

Value ($000) $138 Shares 22,981 Est. Cost $23.94 Unrealized -83.3%

LXEO LEXEO THERAPEUTICS INC 0.5%

Value ($000) $115 Shares 17,332 Est. Cost $13.31 Unrealized -63.7%

IKT INHIBIKASE THERAPEUTICS INC 0.1%

Value ($000) $27 Shares 16,393 Est. Cost $2.49 Unrealized -30.6%

SABS SAB BIOTHERAPEUTICS INC 0.1%

Value ($000) $22 Shares 10,935 Est. Cost $2.26 Unrealized 0.0%

CNTX CONTEXT THERAPEUTICS INC 0.1%

Value ($000) $18 Shares 18,403 Est. Cost $1.72 Unrealized -53.0%

Ticker	Issuer	Shares	Value ($000)	%	Est. Cost	Unrealized	Class	CUSIP
RZLT	REZOLUTE INC	1,986,818	$18,676	81.7%	$8.14	-18.2%	COM NEW	76200L309
GLD	SPDR GOLD TR	7,286	$2,590	11.3%	$310.70	—	GOLD SHS	78463V107
BRK/B	BERKSHIRE HATHAWAY INC DEL	651	$327	1.4%	$401.81	+20.5%	CL B NEW	084670702
—	MIND MEDICINE MINDMED INC	27,011	$318	1.4%	$8.91	—	COM NEW	60255C885
ELVN	ENLIVEN THERAPEUTICS INC	13,097	$268	1.2%	$18.93	+6.5%	COM	29337E102
CMPX	COMPASS THERAPEUTICS INC	53,503	$187	0.8%	$3.22	-1.9%	COM	20454B104
BCAX	BICARA THERAPEUTICS INC	10,941	$173	0.8%	$25.50	-56.1%	COM	055477103
KYTX	KYVERNA THERAPEUTICS INC	22,981	$138	0.6%	$23.94	-83.3%	COM	501976104
LXEO	LEXEO THERAPEUTICS INC	17,332	$115	0.5%	$13.31	-63.7%	COM	52886X107
IKT	INHIBIKASE THERAPEUTICS INC	16,393	$27	0.1%	$2.49	-30.6%	COM NEW	45719W205
SABS	SAB BIOTHERAPEUTICS INC	10,935	$22	0.1%	$2.26	0.0%	COM NEW	78397T202
CNTX	CONTEXT THERAPEUTICS INC	18,403	$18	0.1%	$1.72	-53.0%	COM	21077P108